BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Society of Cannabis Clinicians - ECPv6.15.15//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Society of Cannabis Clinicians
X-ORIGINAL-URL:https://www.cannabisclinicians.org
X-WR-CALDESC:Events for Society of Cannabis Clinicians
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250108T200000
DTEND;TZID=America/New_York:20250108T210000
DTSTAMP:20260608T013236
CREATED:20241231T155916Z
LAST-MODIFIED:20250107T151659Z
UID:10000174-1736366400-1736370000@www.cannabisclinicians.org
SUMMARY:January Cerium Journal Club - Challenging the Dogma: Does High-Dose CBD Potentiate THC's Psychoactive Effects? (Host: Jahan Marcu)
DESCRIPTION:About\nChallenging the Dogma: Does High-Dose CBD Potentiate THC’s Psychoactive Effects? \nEvent Description:\nJoin us for a journal club where we will discuss the complex interaction between cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC). This session will explore a randomized\, double-blind\, placebo-controlled\, five-way crossover trial that investigated whether CBD counteracts the adverse effects of THC and enhances its analgesic properties. The study involved 37 healthy volunteers who received different combinations of THC and CBD or a double placebo on separate visits. This journal club is relevant for researchers\, healthcare professionals\, and anyone interested in understanding the intricate relationship between CBD and THC\, particularly those involved in cannabis research\, clinical practice\, or policy-making. \nFeatured Article:\nGorbenko\, A. A. et al. Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ 9 ‐Tetrahydrocannabinol Without Improving Its Analgesic Properties. Clin. Pharmacol. Ther. (2024) doi:10.1002/cpt.3381. \nSpeakers:\nPhil Molloy\, MD – Clinical education expert\nTeresa Simon\, MPH – Public health epidemiologist\nJahan Marcu\, PhD – Cannabis researcher \nQuestions? Email Prctrials.info@gmail.com \nPRC+ has education modules available for health care professionals: https://www.prc-trials-plus.com/education \nRegister
URL:https://www.cannabisclinicians.org/event/january-cerium-journal-club-challenging-the-dogma-does-high-dose-cbd-potentiate-thcs-psychoactive-effects-host-jahan-marcu/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2024/12/TWw3uMmnyw78A9p2g.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250109T223000
DTEND;TZID=America/Los_Angeles:20250109T233000
DTSTAMP:20260608T013236
CREATED:20241231T160605Z
LAST-MODIFIED:20250109T143732Z
UID:10000175-1736461800-1736465400@www.cannabisclinicians.org
SUMMARY:Special Webinar: Shaping Federal Cannabis/Cannabinoid Policy Under Fire by Steph Sherer (Americans for Safe Access)
DESCRIPTION:About\nFrom Tipping Point to Breaking Point: Shaping Federal Cannabis/Cannabinoid Policy Under Fire \nUnpack developments and trends from this Congressional session\, learn how the election will impact cannabis/cannabinoid policy\, and learn the critical need for physicians and health experts to be visible on Capitol Hill to ensure policy changes pave the way for an expanded definition of medicine rather than cementing a new chapter in prohibition. \nMeet the Speaker: \nSteph Sherer is the foremost international leader and expert on medical cannabis patient advocacy. Her direct experiences with the medical benefits of cannabis and political organizing led Sherer to form Americans for Safe Access (ASA) in 2002\, with the purpose of building a strong movement to protect patients and their rights and transform US policy to allow for the recognition of cannabis as medicine. Today\, ASA is the largest national patient-centric organization of medical cannabis\, wellness\, and healthcare stakeholders\, addressing knowledge\, policy\, and regulatory gaps to ensure access to cannabis for therapeutic use and research. \n  \nSherer is a powerful advocate\, a skilled spokesperson\, and an energetic initiator of strategic campaigns. For over two decades\, she has pursued ASA’s vision by articulating the immediate needs of patients and incorporating strategies across many disciplines to break down political\, social\, academic\, and legal barriers and clear the way for a national medical cannabis program and a pathway for the federal recognition of botanical cannabis medicines. \n  \nSherer has devoted her career to disrupting policies perpetuating health inequalities and investing in innovative solutions to close the divide between wellness and medicine. Under her leadership\, ASA has achieved many milestones toward its goals\, including developing and implementing state medical cannabis access programs\, protecting state laws through impact litigation\, ending the federal interference with state medical cannabis programs\, creating federal protections for medical professionals\, creating product safety standards for the cannabis and hemp supply chain and trainings for regulators and workers to adhere to them\, participating in efforts to reschedule cannabis in the U.S.\, supporting the FDA with a new approach and data to establish “currently accepted medical use\,” removing federal barriers to research\, coordinating efforts at the World Health Organization (WHO) to recognizes the therapeutic uses of cannabis\, and ultimately changing the schedule of cannabis in internationally. \n  \nSherer is returning to the role of Executive Director after spending several years advancing federal medical cannabis frameworks abroad\, guiding cutting-edge research initiatives\, and reforming international drug treaties. Sherer will lead a renewed\, nationwide effort to fully integrate cannabis-based medicines into the U.S. healthcare system. \nRegister
URL:https://www.cannabisclinicians.org/event/special-webinar-shaping-federal-cannabis-cannabinoid-policy-under-fire-by-steph-sherer-americans-for-safe-access/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2024/12/SCC-Special-Webinar-with-Steph-Sherer-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250117T130000
DTEND;TZID=America/New_York:20250117T140000
DTSTAMP:20260608T013236
CREATED:20241111T150727Z
LAST-MODIFIED:20241111T154008Z
UID:10000173-1737118800-1737122400@www.cannabisclinicians.org
SUMMARY:Everything You Need to Know about CBD
DESCRIPTION: \nOver more than 20 years Dr. Kirsten Shepard has established integrated practices that combine medical\, chiropractic\, acupuncture and physical therapy approaches to whole body care\, including the opening of clinics across Texas and in Los Angeles. \nDr. Kirsten Shepard is an expert in her field; she has led educational sessions with other medical professionals and been recognized by notable leaders across health and fitness communities. She has been selected as a Profile of Prominence award recipient in Health Professions by the Texas legislature and received a Special Congressional Recognition from a Texas United States Senator. \nRegister
URL:https://www.cannabisclinicians.org/event/everything-you-need-to-know-about-cbd/
ATTACH;FMTTYPE=image/webp:https://www.cannabisclinicians.org/wp-content/uploads/2024/11/Live_Class_and_YT_Thumbnails.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250122T223000
DTEND;TZID=America/Los_Angeles:20250122T233000
DTSTAMP:20260608T013236
CREATED:20241231T160934Z
LAST-MODIFIED:20241231T160934Z
UID:10000176-1737585000-1737588600@www.cannabisclinicians.org
SUMMARY:CannaConnect: January Members Call -- Getting the most out of your membership (Hosted by SCC Staff)
DESCRIPTION:About\nWelcome to our members-only event series\, CannaConnect! \nJoin SCC Program Director Christine Milentis and Membership & Communications Director Erin Pully for the first CannaConnect meeting of 2025! \nDuring this informal gathering you will have the opportunity to meet and network with other members\, learn more about our committee relaunch\, membership benefits\, and discuss ways in which you can be involved in furthering SCC initiatives in 2025 and beyond. \nJoin us to ask any questions you might have about seeking resources in the medical cannabis space. There will be a membership Q&A so that you can learn how to make the most of your member benefits and we will be able to walk you through any technical difficulties that are prohibiting you from interacting in the SCC membership portal. \nEach future month of CannaConnect will be hosted by a member of the SCC Board of Directors and will offer an interactive blend of networking\, clinical case discussions\, and the latest in cannabis news. You are invited to come connect with fellow SCC members\, find or offer mentorship\, share insights on clinical practices\, and welcome new members to our thriving community. \nThank you for being part of the Society! \nRegister
URL:https://www.cannabisclinicians.org/event/cannaconnect-january-members-call-getting-the-most-out-of-your-membership-hosted-by-scc-staff/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2024/12/SCC-Cannaconnect-25-with-Christine-and-Erin-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250205T063000
DTEND;TZID=America/Los_Angeles:20250205T073000
DTSTAMP:20260608T013236
CREATED:20241231T161309Z
LAST-MODIFIED:20241231T161309Z
UID:10000177-1738737000-1738740600@www.cannabisclinicians.org
SUMMARY:February Cerium Journal Club - Decoding the Clinical Spectrum of Semisynthetic Cannabinoid Toxicity (Host: Jahan Marcu)
DESCRIPTION:About\nDecoding the Clinical Spectrum of Semisynthetic Cannabinoid Toxicity \nEvent Description:\nThis journal club will explore the rising public health concern of semisynthetic cannabinoids (SSCs)\, focusing on their toxicity and the increasing reports of associated adverse events. SSCs\, such as hexahydrocannabinol (HHC)\, are often marketed as legal alternatives to traditional cannabis\, but they can have potent and unpredictable effects. The discussion will center on thew case reports by Puri (2024) and Reiter (2024) which describes patients who developed potentially life-threatening symptoms after using synthetic or semi-synthetic cannabinoids. Key discussion points will include the challenges of regulating these substances\, the lack of understanding regarding their long-term effects\, and the need for greater awareness among clinicians and policymakers. \nFeatured Articles:\n1. Puri\, A.\, Costanzo\, F.\, Rivera\, J. & Bujdos\, J. Catatonia Induced by First-Time Use of Synthetic Cannabinoids: A Case Report. Cureus 16\, e53324 (2024).\n2. Reiter\, N. et al. Severe poisoning with semi-synthetic cannabinoids. Ugeskr. Læg. 186\, 1–5 (2024).\n3. O’Mahony\, B.\, O’Malley\, A.\, Kerrigan\, O. & McDonald\, C. HHC-induced psychosis: a case series of psychotic illness triggered by a widely available semisynthetic cannabinoid. Ir. J. Psychol. Med. 1–4 (2024) doi:10.1017/ipm.2024.3. \nSpeakers:\nPhil Molloy\, MD – Clinical education expert\nTeresa Simon\, MPH – Public health epidemiologist\nJahan Marcu\, PhD – Cannabis researcher \nQuestions? Email Prctrials.info@gmail.com \nPRC+ has education modules available for health care professionals: https://www.prc-trials-plus.com/education \nRegister
URL:https://www.cannabisclinicians.org/event/february-cerium-journal-club-decoding-the-clinical-spectrum-of-semisynthetic-cannabinoid-toxicity-host-jahan-marcu/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2024/12/DXYwNiNTb3FkFNrfr.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250213T090000
DTEND;TZID=America/Los_Angeles:20250213T100000
DTSTAMP:20260608T013236
CREATED:20241231T161602Z
LAST-MODIFIED:20250207T155921Z
UID:10000178-1739437200-1739440800@www.cannabisclinicians.org
SUMMARY:CannaConnect: February Members Call -- Cannabis & Sex (Hosted by Dr. Windi Muraszka)
DESCRIPTION:About \nWelcome to our members-only event series\, CannaConnect! \nYou are invited to attend the February meeting\, hosted by SCC Board Member\, Dr. Windi Muraszka\, for a conversational gathering to meet and network with other members. She will be presenting newly released research on the topic of cannabis and sex. \nJoin us to ask any questions you might have about seeking resources in the medical cannabis space. Each month of CannaConnect is hosted by a member of the SCC Board of Directors and will offer an interactive blend of networking\, clinical case discussions\, and the latest in cannabis news. You are invited to come connect with fellow SCC members\, find or offer mentorship\, share insights on clinical practices\, and welcome new members to our thriving community. \nThank you for being part of the Society! \nRegister
URL:https://www.cannabisclinicians.org/event/cannaconnect-february-members-call-cannabis-sex-hosted-by-dr-windi-muraszka/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2024/12/SCC-Cannaconnect-25-with-Windi-Muraszka-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20250326T090000
DTEND;TZID=America/Denver:20250326T100000
DTSTAMP:20260608T013236
CREATED:20241231T161945Z
LAST-MODIFIED:20250207T104236Z
UID:10000179-1742979600-1742983200@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: Exploring Evidence-Based Cannabis Treatment Algorithms with CannaKeys
DESCRIPTION:About\nJoin us to hear from SCC partner\, CannaKeys. The CannaKeys team strives to demystify the emerging field of the cannabinoid health sciences and reinforce the proper pathways for patient care utilizing cannabis and related therapies. They do this by creating platforms that offer easy access to the published science\, aggregated critical data points\, and guidance to practitioners and patients to ask the right questions and achieve optimal results more quickly. \nEvent Description:\nThe increasing use of cannabis for therapeutic purposes presents both opportunities and challenges for clinicians. From a harm reduction perspective and a commitment to generating optimal patient outcomes\, it is crucial for healthcare professionals to access reliable\, evidence-based information on cannabinoid-based therapies—particularly for chronic conditions that respond inadequately to conventional treatments. \nIn this interactive Zoom session\, we will explore CannaKeys’ condition-specific treatment algorithms\, grounded in the latest scientific evidence and designed to enhance clinical decision-making. We will examine their utility and limitations in evaluating patients\, customizing cannabinoid-based therapies\, and addressing practical considerations in clinical practice. \nThe presentation will be followed by a Q&A discussion to foster a conversational atmosphere\, allowing participants to share insights\, ask questions\, and engage in dialogue about the integration of evidence-based cannabis therapeutics in clinical care. \nRegister\n  \nBios: \nUwe Blesching\, PhD \nWith nearly 20 years of experience in emergency medical services at the San Francisco Department of Public Health (Paramedic Division)\, Dr. Uwe Blesching\, Ph.D.\, offers invaluable insights into how the choices we make and the drugs we take—both pharmaceutical and recreational—impact the body\, mind\, and spirit. He is the author of several acclaimed works\, including The Cannabis Health Index (3rd edition)\, Breaking the Cycle of Opioid Addiction\, and Your Cannabis CBD: THC Ratio (2nd edition). Challenging conventional views on the war on drugs\, Dr. Blesching’s research and expertise highlight the potential of mind-altering plants and practices\, when approached through evidence-based frameworks\, to play a vital role in preventing and treating chronic conditions. He is also the co-founder and chief science officer at CannaKeys\, where he continues to bridge science\, wellness\, and innovation. \n  \nDave Rosenthal\, MFA \nDavid Rosenthal is Co-Founder and Chief Technology Officer (CTO) of CannaKeys\, where he develops innovative tools to help researchers\, healthcare professionals\, and patients navigate the science of the endocannabinoid system. Converting complex scientific data into user-friendly applications\, David has been instrumental in establishing CannaKeys as a reliable platform for evidence-based insights into the ECS and cannabis therapeutics.
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-exploring-evidence-based-cannabis-treatment-algorithms-with-cannakeys/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2024/12/ZrMQWbk7TQpCjYQ9R-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250416T120000
DTEND;TZID=America/New_York:20250416T130000
DTSTAMP:20260608T013236
CREATED:20250331T135519Z
LAST-MODIFIED:20250331T135659Z
UID:10000181-1744804800-1744808400@www.cannabisclinicians.org
SUMMARY:CannaConnect: April Members Call -- Hosted by SCC President Dr. Stephen Robinson
DESCRIPTION:Welcome to our members-only event series\, CannaConnect! \nYou are invited to attend the April meeting\, hosted by SCC President\, Dr. Stephen Robinson\, for a conversational gathering to meet and network with other members. \nJoin us to ask any questions you might have about seeking resources in the medical cannabis space. Each month of CannaConnect is hosted by a member of the SCC Board of Directors and will offer an interactive blend of networking\, clinical case discussions\, and the latest in cannabis news. You are invited to come connect with fellow SCC members\, find or offer mentorship\, share insights on clinical practices\, and welcome new members to our thriving community. \nThank you for being part of the Society! \nRegister
URL:https://www.cannabisclinicians.org/event/cannaconnect-april-members-call-hosted-by-scc-president-dr-stephen-robinson/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2025/03/SCC-Cannaconnect-April-members-call-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250515T120000
DTEND;TZID=America/New_York:20250515T130000
DTSTAMP:20260608T013236
CREATED:20250331T140023Z
LAST-MODIFIED:20250331T140023Z
UID:10000182-1747310400-1747314000@www.cannabisclinicians.org
SUMMARY:CannaConnect: May Members Call -- Cannabis Pharmacy (Hosted by Dr. Bobby Vincent III)
DESCRIPTION:Welcome to our members-only event series\, CannaConnect! \nYou are invited to attend the May meeting\, hosted by SCC Board Member\, Dr. Bobby Vincent III\, for a conversational gathering to meet and network with other members. This meeting will focus on the role of pharmacists in the medical cannabis industry. Please join to contribute your perspective\, share updates with the group\, and bring any questions that you would like addressed. \nEach month of CannaConnect is hosted by a member of the SCC Board of Directors and will offer an interactive blend of networking\, clinical case discussions\, and the latest in cannabis news. You are invited to come connect with fellow SCC members\, find or offer mentorship\, share insights on clinical practices\, and welcome new members to our thriving community. \nThank you for being part of the Society! \nRegister
URL:https://www.cannabisclinicians.org/event/cannaconnect-may-members-call-cannabis-pharmacy-hosted-by-dr-bobby-vincent-iii/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2025/03/SCC-Cannaconnect-May-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250612T120000
DTEND;TZID=America/New_York:20250612T130000
DTSTAMP:20260608T013236
CREATED:20250331T140805Z
LAST-MODIFIED:20250331T140841Z
UID:10000183-1749729600-1749733200@www.cannabisclinicians.org
SUMMARY:CannaConnect: June Members Call -- Cannabis & Cancer (Hosted by Dr. Katia Tonkin)
DESCRIPTION: \nWelcome to our members-only event series\, CannaConnect! \nYou are invited to attend the June meeting\, hosted by SCC Board Member Dr. Katia Tonkin\, for a conversational gathering to meet and network with other members. This meeting will focus on cannabis and cancer. Please join to contribute your perspective\, share updates with the group\, and bring any questions that you would like addressed. \nEach month of CannaConnect is hosted by a member of the SCC Board of Directors and will offer an interactive blend of networking\, clinical case discussions\, and the latest in cannabis news. You are invited to come connect with fellow SCC members\, find or offer mentorship\, share insights on clinical practices\, and welcome new members to our thriving community. \nThank you for being part of the Society! \nRegister
URL:https://www.cannabisclinicians.org/event/cannaconnect-june-members-call-cannabis-cancer-hosted-by-dr-katia-tonkin/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2025/03/SCC-Cannaconnect-June-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250625T120000
DTEND;TZID=America/New_York:20250625T130000
DTSTAMP:20260608T013236
CREATED:20250331T143352Z
LAST-MODIFIED:20250331T143352Z
UID:10000184-1750852800-1750856400@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: The Untold Story of SCC's Activist Legacy
DESCRIPTION:Join us to hear from Dr. Jeffrey Hergenrather and Fred Gardner\, founding members of the Society of Cannabis Clinicians (SCC). This special event will explore the grassroots movement that ignited clinician activism for cannabis as medicine\, leading to the formation of SCC. Through firsthand accounts\, attendees will gain insight into the pivotal moments\, challenges\, and triumphs that shaped the medical cannabis landscape. We invite you all to come along with us for an inspiring journey into the untold history of SCC and its enduring impact on patient care\, policy\, and scientific progress. \nThe presentation will be followed by a Q&A discussion to foster a conversational atmosphere\, allowing participants to share insights\, ask questions\, and engage in dialogue about the past and future of the medical cannabis movement. \nRegister
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-the-untold-story-of-sccs-activist-legacy/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2025/03/SCC-Quarterly-Meeting-June-25-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250716T120000
DTEND;TZID=America/New_York:20250716T130000
DTSTAMP:20260608T013236
CREATED:20250331T143716Z
LAST-MODIFIED:20250331T143716Z
UID:10000185-1752667200-1752670800@www.cannabisclinicians.org
SUMMARY:CannaConnect: July Members Call -- Integrative Approaches to Cannabis (Hosted by Dr. Patricia Frye)
DESCRIPTION:Welcome to our members-only event series\, CannaConnect! \nYou are invited to attend the July meeting\, hosted by SCC Board Member Dr. Patricia Frye\, for a conversational gathering to meet and network with other members. This meeting will focus on integrative approaches to optimize cannabis therapeutics. Please join to contribute your perspective\, share updates with the group\, and bring any questions that you would like addressed. \nEach month of CannaConnect is hosted by a member of the SCC Board of Directors and will offer an interactive blend of networking\, clinical case discussions\, and the latest in cannabis news. You are invited to come connect with fellow SCC members\, find or offer mentorship\, share insights on clinical practices\, and welcome new members to our thriving community. \nThank you for being part of the Society! \nRegister
URL:https://www.cannabisclinicians.org/event/cannaconnect-july-members-call-integrative-approaches-to-cannabis-hosted-by-dr-patricia-frye/
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2025/03/SCC-Cannaconnect-July-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250919T080000
DTEND;TZID=America/Los_Angeles:20250921T170000
DTSTAMP:20260608T013236
CREATED:20250515T180015Z
LAST-MODIFIED:20250515T180015Z
UID:10000186-1758268800-1758474000@www.cannabisclinicians.org
SUMMARY:2025 National Interdisciplinary Cannabis Symposium
DESCRIPTION:2025 National Interdisciplinary Cannabis Symposium\n9/19-21\, 2025\nUniversity Denver Sturm College of Law\n2255 E. Evans Ave. Denver\, Colorado 80210 \nAs of now\, medical marijuana is legalized in 40 states\, with an additional 24 states\, along with D.C.\, Guam\, the Northern Mariana Islands\, and various Tribal nations\, enacting laws permitting adult use of marijuana. Numerous other states are exploring legislation and referenda to legalize recreational marijuana in 2025. \nThese evolving legal shifts are profoundly influencing our legal system\, families\, and society at large. They present a dynamic and occasionally intricate terrain for a multitude of professions\, including Law Enforcement\, Judiciary\, Legal Practitioners\, Specialty Court Experts\, Scientific Community\, Drug and Alcohol Testing Sector\, Academia\, Cannabis Industry as well as Employment and Human Resource Associations & Organizations. \nOur Symposium is a platform to bring together these diverse disciplines\, each offering unique perspectives. Through education and collaboration\, NICS\, a 501C3\, seeks to foster a comprehensive understanding of cannabis-related issues across disciplines. \nAttendees can expect to engage in insightful discussions and networking opportunities\, as the symposium aims to bridge gaps between different fields of study and the evolving cannabis industry. Participants will have the chance to learn from distinguished speakers and industry leaders\, making it an essential event for anyone interested in the multifaceted aspects of cannabis education. We warmly invite you to join us and engage in this enriching event! \nThe proceeds generated from the Symposium will cover operational costs and serve as seed funding for future endeavors. Any surplus funds will be donated to 501(C)(3) organizations.   \nThrough initiatives such as scholarships for law students (anyone interested please download the scholarship application here send an email to nicsstudentscholarship@gmail.com) and assistance with speaker travel expenses\, we endeavor to foster accessibility. \nRegister
URL:https://www.cannabisclinicians.org/event/2025-national-interdisciplinary-cannabis-symposium/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2025/05/Screenshot-2025-05-15-at-16.35.01-1-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20251024T130000
DTEND;TZID=America/Denver:20251025T170000
DTSTAMP:20260608T013236
CREATED:20250206T151618Z
LAST-MODIFIED:20250721T161610Z
UID:10000180-1761310800-1761411600@www.cannabisclinicians.org
SUMMARY:SCC 3rd Annual Medical Cannabis Conference
DESCRIPTION:  \nSCC 3rd Annual Medical Cannabis Conference\nOctober 24 (1pm Mountain Time) – October 25 (5pm Mountain Time) \nThis year’s two-day event will bring together the brightest minds and leading experts across the medical cannabis industry for a two days of education\, innovation\, and collaboration. Whether you’re a healthcare professional\, patient advocate\, researcher\, or industry leader\, this event is designed to empower you with the latest insights\, research\, and best practices in medical cannabis. \nWhat to Expect at MedCannCon25: \n\nKeynote presentations from renowned medical cannabis experts\nPanel discussions on cutting-edge research\, patient care\, and industry trends\nNetworking opportunities with professionals and advocates in the field\nExhibitors from across the industry\nAnd more!\n\nDetails \nWhere: Tivoli Turnhall at Auraria Campus (Denver\, CO)\nWhen: October 24-25\, 2025 \nRegistration Now Open! \nStay tuned for early bird discounts and exclusive opportunities to secure your spot at this premier event. \nWe can’t wait to see you in Denver for what promises to be our most impactful MedCannCon yet! Together\, we can continue to advance education\, advocacy\, and access in the medical cannabis community. \nRegister
URL:https://www.cannabisclinicians.org/event/scc-3rd-annual-medical-cannabis-conference/
ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2025/04/Medcancon25-Denver-web-banner-01-res-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251218T090000
DTEND;TZID=America/Los_Angeles:20251218T100000
DTSTAMP:20260608T013236
CREATED:20251214T153654Z
LAST-MODIFIED:20251224T154459Z
UID:10000188-1766048400-1766052000@www.cannabisclinicians.org
SUMMARY:A Century of Advocacy & Care: Experts Respond to Federal Hemp THC Limits
DESCRIPTION:Experts Discuss New Regulatory Pathways \nThree of the nation’s leading cannabis advocacy and patient-care organizations—the National Organization for the Reform of Marijuana Laws (NORML\, founded 1970)\, the Society of Cannabis Clinicians (SCC\, founded 1999)\, and the Marijuana Policy Project (MPP\, founded 1995)—are coming together for a timely public webinar in response to recent federal changes impacting hemp-derived THC. With over a century of combined experience advancing sensible cannabis policy\, patient protections\, and evidence-informed clinical care\, this panel will offer a clear\, grounded conversation about what’s changing\, what it means\, and what comes next. \nEach organization will share a concise 10–15 minute recap of key highlights and takeaways from their recent briefings and community updates\, followed by a moderated Q&A panel where participants can ask questions and hear multiple perspectives in one place. \nAttendees can expect: \n\nPlain-language context on the federal hemp THC limits and their significance.\nPractical implications for patient access\, product availability\, safety\, and counseling.\nAdvocacy priorities and consumer-facing guidance from each organization.\nA collaborative\, solutions-oriented discussion to guide collective action in 2026.\nJoin us for an informed\, community-centered conversation that reflects the strength of our diversity—different angles\, complementary expertise\, and a shared commitment to responsible policy and patient care.\n\nRegister
URL:https://www.cannabisclinicians.org/event/a-century-of-advocacy-care-experts-respond-to-federal-hemp-thc-limits/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20251218T110000
DTEND;TZID=America/Los_Angeles:20251218T120000
DTSTAMP:20260608T013236
CREATED:20251214T153022Z
LAST-MODIFIED:20251224T153254Z
UID:10000187-1766055600-1766059200@www.cannabisclinicians.org
SUMMARY:Rooted in Evidence: SCC’s Holiday Research Showcase
DESCRIPTION:Join the Society of Cannabis Clinicians for a special end-of-year webinar and festive social gathering—ugly Christmas sweaters encouraged. \nWe’ll be unveiling our latest project\, which tackles one of the biggest misunderstandings in modern medicine: Rooted in Evidence: Cannabis\, Pharmaceuticals\, and the Case for Reform. \nThis session breaks down why botanical\, whole-plant therapeutics fundamentally don’t fit into the FDA’s traditional pharmaceutical pathway\, how this mismatch has shaped policy and clinical access\, and why the limitations of the pharma framework do not diminish the legitimacy\, efficacy\, or scientific rigor of cannabis medicine. \nYou’ll learn: \nHow the unique complexity of whole-plant cannabis challenges single-compound pharmaceutical standards\nWhy the FDA drug-development pathway is structurally incompatible with multi-molecule botanicals\nWhat this means for research\, evidence generation\, clinical practice\, and patient access\nHow SCC’s new project provides a roadmap for responsible clinical integration outside the pharmaceutical paradigm \nAfter the presentation\, stay for our virtual Ugly Christmas Sweater Social where clinicians\, researchers\, and advocates can connect\, share insights\, and celebrate the close of another transformational year in cannabis medicine. \nKnowledge\, community\, and questionable holiday fashion—all in one event. \n*Open to SCC members and the broader medical cannabis community.* \nRegister
URL:https://www.cannabisclinicians.org/event/rooted-in-evidence-sccs-holiday-research-showcase/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260106T090000
DTEND;TZID=America/Los_Angeles:20260106T100000
DTSTAMP:20260608T013236
CREATED:20251224T155741Z
LAST-MODIFIED:20251224T155741Z
UID:10000189-1767690000-1767693600@www.cannabisclinicians.org
SUMMARY:January Journal Club - A Puff Before a Pour: Dose-Dependent Effects of Cannabis on Drinking (Host: Jahan Marcu @ Cerium)
DESCRIPTION:About \nA Puff Before a Pour: Dose-Dependent Effects of Cannabis on Drinking \nEvent Description: \nThis month’s journal club will examine a landmark randomized controlled crossover trial exploring how smoked cannabis affects alcohol craving and consumption under controlled laboratory conditions. With the rise of THC beverages\, “Cali sober” trends\, and increasing co-use of cannabis and alcohol\, this study provides some of the strongest causal evidence to date on whether THC increases or decreases drinking. We will review the study’s design\, outcomes\, and implications for clinical practice\, harm-reduction counseling\, and public health messaging. \nKey takeaway: Smoking cannabis with THC (3.1% and 7.2%) significantly reduced alcohol consumption by 19–27% compared to placebo\, with nuanced effects on craving and urge. \nFeatured Article: \nMetrik J\, Aston ER\, Gunn RL\, Swift R\, MacKillop J\, Kahler CW.\nAcute Effects of Cannabis on Alcohol Craving and Consumption: A Randomized Controlled Crossover Trial. American Journal of Psychiatry. 2025; XX:1–9. \nDOI: TBA. \nSpeakers: \nPhil Molloy\, MD – Clinical education expert\nTeresa Simon\, MPH – Public health epidemiologist\nLen Kamen\, MD – Clinical pain specialist\nJahan Marcu\, PhD – Cannabis researcher \nRegister
URL:https://www.cannabisclinicians.org/event/january-journal-club-a-puff-before-a-pour-dose-dependent-effects-of-cannabis-on-drinking-host-jahan-marcu-cerium/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260108T090000
DTEND;TZID=America/Los_Angeles:20260108T100000
DTSTAMP:20260608T013236
CREATED:20251215T160108Z
LAST-MODIFIED:20251224T161615Z
UID:10000190-1767862800-1767866400@www.cannabisclinicians.org
SUMMARY:SCC CannaConnect Roundtable: Patient-Reported Outcomes (January)
DESCRIPTION:About \nWelcome to our members-only monthly event series\, CannaConnect Roundtable! \nThis month is hosted by E.R.I.C. Cancer Playbook\, powered by Whole Health Oncology Institute on the topic of patient-reported outcomes. \nPatient-reported outcomes (PROs)—what patients tell us about their symptoms\, function\, and quality of life—are transforming how we evaluate cancer care and integrative therapies\, including medical cannabis. PROs can capture real-world benefits and harms that often don’t show up in traditional clinician-reported measures or survival endpoints\, and they are increasingly used alongside randomized controlled trials (RCTs) to guide care. \nThis interactive discussion hour is designed for clinicians\, researchers\, and patient advocates who want to use patient voice and real-world data to inform safer\, more effective\, and more person-centered cannabis care in oncology. \nEach month of CannaConnect is hosted by a member of the SCC and will offer an interactive blend of networking\, clinical case discussions\, and the latest in cannabis news. You are invited to come connect with fellow SCC members\, find or offer mentorship\, share insights on clinical practices\, and welcome new members to our thriving community. \nThank you for being part of the Society! \nRegister
URL:https://www.cannabisclinicians.org/event/scc-cannaconnect-roundtable-patient-reported-outcomes-january/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260304T090000
DTEND;TZID=America/Los_Angeles:20260304T100000
DTSTAMP:20260608T013236
CREATED:20251215T161533Z
LAST-MODIFIED:20251224T161615Z
UID:10000191-1772614800-1772618400@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: Leveraging Social Science for Social Progress on Psychedelics (Abel Gustafson\, PhD & Matt Goldberg\, PhD)
DESCRIPTION:About \nPsychedelic therapies are becoming more visible in both clinical research and public discourse\, and patients often look to cannabis clinicians for trustworthy\, evidence-based insights. While cannabis and psychedelics are distinct modalities\, they share overlapping patient populations\, therapeutic goals\, and sociopolitical challenges. As these treatments gain momentum\, clinicians must be prepared to discuss them responsibly\, dispel common myths\, and stay informed about emerging evidence. In alignment with the SCC’s mission to share clinical knowledge and promote best practices in cannabinoid medicine\, this session offers essential context to help clinicians navigate this rapidly evolving landscape. \nDescription:\nThere has been a significant resurgence in clinical and public interest in the ability of psychedelics to treat mental illness and generate meaningful personal experiences. However\, there are still formidable barriers in public perception that could thwart progress in policy\, research\, and therapeutic uses. These barriers include people’s beliefs and (mis)understanding of psychedelics\, persistent myths about them\, and a lack of understanding of their uses and benefits. XandY\, an independent research and strategy firm\, conducted a nationally-representative study of the US public to understand how Americans think about psychedelics and which policies they support regarding their use. In this presentation\, XandY co-founders will present those findings and discuss strategies for designing communication efforts that can cultivate public support for psychedelic research\, therapies\, and decriminalization in the United States. \nBios: \nMatthew Goldberg\, Ph.D.\nDr. Matthew Goldberg is one of the world’s leading scientific experts on persuasion\, human behavior\, and public opinion. He has developed custom research insights for tech companies\, media companies\, political figures\, and nonprofits\, and has published dozens of peer-reviewed scientific studies. He earned his Ph.D. in Social Psychology and is a faculty research scientist at Yale University. \nAbel Gustafson\, Ph.D.\nDr. Abel Gustafson is one of the world’s leading scientific experts on social psychology and communication strategy. He has provided research solutions and strategic consulting for multi-national corporations\, tech startups\, media networks\, political figures\, and NGOs\, and has published dozens of peer-reviewed scientific studies. After earning his Ph.D.\, he joined Yale University to conduct research on communication strategies related to science\, sustainability\, and emerging tech. He is a professor of public relations at the University of Cincinnati. \nRegister
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-leveraging-social-science-for-social-progress-on-psychedelics-abel-gustafson-phd-matt-goldberg-phd/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260624T090000
DTEND;TZID=America/Los_Angeles:20260624T100000
DTSTAMP:20260608T013236
CREATED:20251215T162102Z
LAST-MODIFIED:20251224T162130Z
UID:10000192-1782291600-1782295200@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: Navigating Integrative Cancer Care: Cannabis\, Psychedelics & Supportive Therapies (Stacy D’Andre\, MD\, Mayo Clinic)
DESCRIPTION:About \nJoin us for an insightful presentation by Dr. Stacy D’Andre\, a board‐certified oncologist at Mayo Clinic with a dedicated focus on integrative oncology\, including the safe and evidence‐informed use of medical cannabis and medicinal mushrooms. \nIn this session\, Dr. D’Andre will: \n\nProvide an update on her recent research efforts in medical cannabis for oncology‐related symptom management—such as her pilot randomized placebo‐controlled trial of topical cannabidiol for chemotherapy‐induced neuropathy.\nExplore emerging work and considerations around psychedelic therapies in the context of cancer care and supportive medicine—highlighting the overlap in patient populations\, clinical questions\, and integrative care frameworks.\nDiscuss the practical implications for clinicians: how to address patient inquiries about cannabis or psychedelic‐adjunctive therapies\, integrate conversations into care plans\, evaluate the growing body of evidence\, and incorporate best practices in an evolving regulatory and clinical landscape.\n\nRegister
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-navigating-integrative-cancer-care-cannabis-psychedelics-supportive-therapies-stacy-dandre-md-mayo-clinic/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260902T090000
DTEND;TZID=America/Los_Angeles:20260902T100000
DTSTAMP:20260608T013236
CREATED:20251215T162441Z
LAST-MODIFIED:20251224T162505Z
UID:10000193-1788339600-1788343200@www.cannabisclinicians.org
SUMMARY:SCC Quarterly Meeting: Emerging Insights from Alzheimer’s Research (Duncan Mackie\, PhD)
DESCRIPTION:About \nSpeaker: \nDuncan Mackie\, PhD\, Director of Pharmacology & Experimental Therapeutics\, MedPharm Holdings \nEvent Description: \nAlzheimer’s disease remains one of the most challenging neurodegenerative conditions to treat\, and interest is growing in how cannabinoids might modulate key pathways involved in its progression. MedPharm Holdings\, a Denver-based cannabis research and formulation development company\, has focused its R&D program on neuropharmacology—particularly Alzheimer’s disease and dementia—leveraging one of Colorado’s first cannabis research licenses and a federal Schedule I research license to systematically study cannabis-derived compounds. \nIn this presentation\, Dr. Duncan Mackie will share emerging findings from his ongoing work conducted in collaboration with academic partners through Colorado State University’s Institute of Cannabis Research. This project investigates how specific phytocannabinoids may influence Alzheimer’s-related mechanisms\, with an emphasis on neuroinflammation\, neuronal health\, and potential disease-modifying pathways. \nBio: \nDr. Duncan I. Mackie is the Director of Pharmacology and Experimental Therapeutics at Bud & Mary’s\, where he leads innovative research in drug discovery\, cellular and molecular biology\, and G-protein-coupled receptor (GPCR) pharmacology to explore the therapeutic potential of cannabinoids. His work focuses on their interactions with the endocannabinoid system\, with the goal of identifying novel drug targets and developing new treatments for complex diseases. He is one of only a small number of investigators in the United States to hold a Federal DEA Schedule I Researcher license to study cannabis and cannabinoids\, which uniquely positions his laboratory to advance translational research in this rapidly evolving field. \nA recognized leader in cannabis research\, Dr. Mackie has established a rigorous\, externally funded research program focused on the role of the endocannabinoid system in modulating immune function during the onset and progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. His wide-ranging research interests span all areas of cannabis and cannabinoid research\, from development of analytical and regulatory testing methods\, investigations into label compliance and quality standards\, cellular and mechanistic studies of cannabinoid signaling\, creation of biosensors and high-throughput pharmacology assays\, and the design of advanced preclinical models of neuroinflammation. He is also actively involved in clinical translation research\, contributing to FDA-approved clinical trials. \nDr. Mackie has published in leading journals including the Proceedings of the National Academy of Sciences and Journal of Experimental Medicine\, and he is an inventor on multiple patents arising from his discoveries. He is a sought-after speaker and lecturer on cannabis and science-related topics at various conferences and events\, and he mentors students and trainees through his role as a Graduate Faculty member in the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus. Additionally\, he is the Chair of the Cannabis Program Advisory Board at the Community College of Denver and as an Associate Editor for the Journal of Cannabis Research\, reflecting his dedication to advancing cannabis science through both education and scholarly publishing. \nHe earned his B.S. in Mathematics from the University of the Cumberlands and his Ph.D. in Medicinal and Natural Products Chemistry from the Pharmaceutical Sciences and Experimental Therapeutics Department at the University of Iowa School of Pharmacy and completed his postdoctoral research in the Department of Cellular Biology and Physiology at the University of North Carolina-Chapel Hill. \nRegister
URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-emerging-insights-from-alzheimers-research-duncan-mackie-phd/
END:VEVENT
END:VCALENDAR